Umlaufvermögen Veränderung Datum
Amgen USD 34.36B 598M 2026-09
Bio Techne USD 824.83M 80.43M 2026-09
Cassava Sciences USD 80.06M 3.67M 2026-09
Cytokinetics USD 1.19B 21.34M 2026-09
Exelixis USD 1.32B 70.8M 2026-09
Genmab DKK 2.8B 228M 2026-06
Geron USD 468.74M 17.6M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
Incyte USD 5.52B 505.2M 2026-09
MacroGenics USD 295.08M 26.61M 2026-09
Novartis USD 28.75B 1.4B 2026-09
Novavax USD 707.96M 63.14M 2026-09